Thomas V. O'Halloran, 10% Owner, Director, Officer, Chief Executive Officer, Chief Scientific Officer at Monopar Therapeutics (MNPR), bought 125,000 shares at $8.00 ($1.0M) on 2019-12-18, disclosed to the SEC on 2019-12-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.